Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...
The full-year 2025 return of Maran Partners Fund was +5.4%, net of all fees and expenses, following a fourth quarter return of -5.2%, net. Read more here.
Thank you for standing by, and welcome to the Genesis Minerals Limited Quarterly Activities Report December 2025 Conference Call. [Operator Instructions] I would now like to hand the conference over ...
Casey’s General Stores, Inc. has 14% net income growth and 58.6% food margins with a 36 forward P/E. Read why CASY stock is a ...
Clarus’ results have been tepid following the Covid-era boom in outdoor activities, but it has still generated generally ...
Oxford Square Capital Corp. has a 7.1% yield on OXSQG bonds, 208% asset coverage, and zero non-accruals. Find out why OXSQ ...
Vistra outlook: surging profits, M&A, and PPAs drive 2026 EBITDA to $7.2B and strong FCF. Click for more on VST stock.
Ariel Appreciation Fund outperformed its benchmarks in Q4 2025 behind strong returns from Sphere Entertainment. Read our full ...
Chemours is reiterated as a 'Buy' with a $20 PT and fair value up to $30, reflecting cyclical upside and improved visibility.
Tencent Holdings Limited captures growth from China's services pivot, AI, and five-year plan support with proactive ...
Hercules Capital stands out among BDCs amid SOFR-driven dividend normalization. See here for HTGC's underlying fundamentals and specific market dynamics.
The NZS Growth Equity strategy had a gross return of -1.18% and a net return of -1.35% for Q4 2025. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results